跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,541 条关于
“Gerresheimer AG”
全部
1,541
临床试验
352
药物
376
机构
285
资讯
528
11个月前
FDA Approves Lasix ONYU, First At-Home Subcutaneous Furosemide Infusion Device for Heart Failure
去年
SQ Innovation's Lasix ONYU Receives Tentative FDA Approval for Congestive Heart Failure Treatment
3个月前
Injectable Drug Delivery Devices Market to Reach $1.06 Trillion by 2032, Driven by Biologics Boom and Smart Device Innovation
上个月
North America Prefilled Syringes Market to Reach USD 17.46 Billion by 2035, Driven by Biologics and Home Self-Administration
去年
Fabhalta Demonstrates Sustained Efficacy in Phase III C3 Glomerulopathy Trial
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
2年前
4SC AG Receives MHRA Waiver for Resminostat in Pediatric CTCL
3年前
4SC's Resminostat Advances Towards European Market Approval for CTCL Maintenance Therapy
4年前
RESMAIN Study: Resminostat Shows Promise in Cutaneous T-Cell Lymphoma Maintenance
6年前
RESMAIN Trial of Resminostat for CTCL Maintenance Continues After Positive Safety Review
第 1 页,共 53 页
上一页
下一页